Metabolomics Biomarker Market 2018 Size, Growth Analysis Report, Forecast to 2023

The global metabolomics biomarker market size was accounted at $188 million in 2018 and estimated to grow at a CAGR of 12.2% during the forecast period. The global metabolomics biomarker is growing at a significant rate owing to various factors such as ongoing research on metabolomics biomarker, innovative development in informatics and analytical technologies, and extensive applications such as in the detection of colorectal cancer. The increasing prevalence of colorectal cancer across the globe is one of the major factors for the wide adoption of metabolomics biomarkers for early detection of disease. According to the American Cancer Society, in 2019, the number of new colon cancer cases is estimated to be around 101,420 and the number of new rectal cancer is estimated to be nearly 44,180 in the US. The metabolomics is increasingly being adopted in the development of precision medicines for various chronic diseases such as cancer and CVD. This, in turn, is driving the growth of the global metabolomics biomarker market.

Request a Free Sample of our Metabolomics Biomarker Market: https://www.omrglobal.com/request-sample/metabolomics-biomarker-market

Global metabolomics biomarker market has been segmented on the basis of technology, application, end-user, and regions. On the basis of technology, the market has been segregated into chromatography, mass spectrometry, nuclear magnetic resonance (NMR), and others. The chromatography segment is further sub-segmented into gas chromatography (GC), high-performance liquid chromatography (HPLC), and ultra-performance liquid chromatography (UPLC). Mass-spectrometry combined with chromatography technology is dominating the market share with around 65% contribution to the overall market in 2017. Mass spectrometry along with chromatography analyzes a wide range of metabolites of varying molecular weight; thereby, finds greater adoption across various end-user.

Moreover, the combination has a high peak capacity to cover a wide range of concentrations and detect both hydrophobic and hydrophilic compounds, which supports their adoption in metabolomics in the various end-use application.
The key players operating in the global metabolomics biomarker market include BG Medicine, Inc., Biomark Diagnostics Inc., Evotec A.G., Merck KGaA, Metabolomic Diagnostics Ltd., Stemina Biomarker Discovery, Inc., and Thermo Fisher Scientific, Inc., among others. The companies are developing innovative metabolomics biomarker in the market, in order to develop effective diagnostic and treatment for infectious and metabolic diseases. Furthermore, the market players are adopting various strategies, in order to sustain in the highly competitive market, which includes merger & acquisition, geographical expansion, joint ventures, and product development, among others.

A full Report of Metabolomics Biomarker Market is Available at: https://www.omrglobal.com/industry-reports/metabolomics-biomarker-market

Global Metabolomics Biomarker Market - Segmentation

By Application

• Toxicological Studies
• Drug Testing
• Cancer
• Cardiovascular Disorders
• Neurological Disorders
• Inborn Errors of Metabolism
• Other

By Technologies

• Gas Chromatography (GC)
• High-Performance Liquid Chromatography (HPLC)
• Ultra-Performance Liquid Chromatography (UPLC)
• Nuclear Magnetic Resonance (NMR)
• Mass Spectrometry
• Surface-Based Mass Analysis
• Bioinformatics
• Other

By End Users

• Hospitals
• Diagnostic Labs
• Research Centres

Global Metabolomics Biomarker Market – Segment by Region

North America

• US
• Canada

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• Rest of Asia-Pacific
Rest of the World

• COMPANY PROFILES

AB SCIEX
BG MEDICINE INC.
BIOCRATES LIFE SCIENCES AG
BIOMARK DIAGNOSTICS INC.
CHENOMX INC.
CREATIVE PROTEOMICS.
EVOTEC A.G.
HUMAN METABOLOME TECHNOLOGIES AMERICA, INC.
MERCK KGAA,
METABOLOMIC DIAGNOSTICS LTD.
METABOLON, INC.
METANOMICS HEALTH GMBH
NIGHTINGALE HEALTH
OVID THERAPEUTICS INC.
OWL METABOLOMICS
PROSCIENTO, INC.
SIDMAP LLC
STEMINA BIOMARKER DISCOVERY, INC.
SYSTEM BIOSCIENCES, LLC.
THERMOFISHER SCIENTIFIC INC.

Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/metabolomics-biomarker-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.